How can we promote smoking cessation in people with schizophrenia in practice? A clinical overview

Acta Psychiatrica Scandinavica

Volumn 132, Issue 2, 2015, Pages 122-130

  Stubbs, B ^a   Vancampfort, D ^b   Bobes, J ^c   De Hert, M ^d   Mitchell, A J ^e  

^a UNIVERSITY OF GREENWICH   (United Kingdom)

^b KU LEUVEN DEPARTMENT OF REHABILITATION SCIENCES   (Belgium)

^c UNIVERSITY OF OVIEDO   (Spain)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

psychosis; schizophrenia; serious mental illness; smoking; smoking cessation

Indexed keywords

AMFEBUTAMONE; VARENICLINE;

ARTICLE; BEHAVIOR THERAPY; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; ELECTRONIC CIGARETTE; GROUP THERAPY; HEALTH CARE DISPARITY; HEALTH PROMOTION; HUMAN; KINESIOTHERAPY; MENTAL PATIENT; META ANALYSIS; META ANALYSIS (TOPIC); NICOTINE REPLACEMENT THERAPY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOSOCIAL CARE; SCHIZOPHRENIA; SMOKING; SMOKING CESSATION; SMOKING CESSATION PROGRAM; SYSTEMATIC REVIEW (TOPIC); TOBACCO DEPENDENCE; TRANSCRANIAL DIRECT CURRENT STIMULATION; WEIGHT GAIN; WITHDRAWAL SYNDROME; EXERCISE; PROCEDURES; PSYCHOLOGY; PSYCHOSOCIAL REHABILITATION;

EXERCISE; HEALTH PROMOTION; HUMANS; PSYCHIATRIC REHABILITATION; SCHIZOPHRENIA; SMOKING; SMOKING CESSATION; WEIGHT GAIN;

EID: 84965154024     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/acps.12412     Document Type: Article

References (50)

1. Osborn DPJ, Levy G, Nazareth I, Petersen I, Islam A, King MB. Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Research Database. Arch Gen Psychiatry 2007;64:242–249.
2. Lawrence D, Hancock KJ, Kisely S. The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers. BMJ 2013;346:f2539-f.
3. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 2007;64:1123–1131.
4. Nielsen RE, Uggerby AS, Jensen SOW, McGrath JJ. Increasing mortality gap for patients diagnosed with schizophrenia over the last three decades – a Danish nationwide study from 1980 to 2010. Schizophr Res 2013;146:22–27.
5. Mitchell AJ, Vancampfort D, Sweers K, van Winkel R, Yu W, de Hert M. Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders—a systematic review and meta-analysis. Schizophr Bull 2013;39:306–318.
6. Lord O, Malone D, Mitchell AJ. Receipt of preventive medical care and medical screening for patients with mental illness: a comparative analysis. Gen Hosp Psychiatry 2010;32:519–543.
7. Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. Br J Psychiatry 2000;177:212–217.
8. Rüther T, Bobes J, de Hert M et al. EPA guidance on tobacco dependence and strategies for smoking cessation in people with mental illness. Eur Psychiatry 2014;29:65–82.
9. Callaghan RC, Veldhuizen S, Jeysingh T et al. Patterns of tobacco-related mortality among individuals diagnosed with schizophrenia, bipolar disorder, or depression. J Psychiatr Res 2014;48:102–110.
10. Hartz SM, Pato CN, Medeiros H et al. Comorbidity of severe psychotic disorders with measures of substance use. JAMA Psychiatry 2014;71:248–254.
11. Myles N, Newall HD, Curtis J, Nielssen O, Shiers D, Large M. Tobacco use before, at, and after first-episode psychosis: a systematic meta-analysis. J Clin Psychiatry 2012;73:468–475.
12. Gage SH, Hickman M, Heron J et al. Associations of cannabis and cigarette use with psychotic experiences at age 18: findings from the Avon Longitudinal Study of Parents and Children. Psychol Med 2014;44:3435–3444.
13. Kelly DL, McMahon RP, Wehring HJ et al. Cigarette smoking and mortality risk in people with schizophrenia. Schizophr Bull 2011;37:832–838.
14. Aubin H-J, Rollema H, Svensson TH, Winterer G. Smoking, quitting, and psychiatric disease: a review. Neurosci Biobehav Rev 2012;36:271–284.
15. Lee J, Green MF, Calkins ME et al. Verbal working memory in schizophrenia from the consortium on the genetics of schizophrenia (cogs) study: the moderating role of smoking status and antipsychotic medications. Schizophr Res 2014; pii: S0920-9964(14)00425-3 [Epub ahead of print].
16. Schneider CE, White T, Hass J et al. Smoking status as a potential confounder in the study of brain structure in schizophrenia. J Psychiatr Res 2014;50:84–91.
17. Lê Cook B, Wayne GF, Kafali N, Liu Z, Shu C, Flores M. Trends in smoking among adults with mental illness and association between mental health treatment and smoking cessation. JAMA 2014;311:172–182.
18. Kelly DL, Raley HG, Lo S et al. Perception of smoking risks and motivation to quit among nontreatment-seeking smokers with and without schizophrenia. Schizophr Bull 2012;38:543–551.
19. Banham L, Gilbody S. Smoking cessation in severe mental illness: what works? Addiction 2010;105:1176–1189.
20. Ragg M, Gordon R, Ahmed T, Allan J. The impact of smoking cessation on schizophrenia and major depression. Australas Psychiatry 2013;21:238–245.
21. Ashton M, Rigby A, Galletly C. Do population-wide tobacco control approaches help smokers with mental illness? Aust N Z J Psychiatry 2014;48:121–123.
22. Ioannidis JP. Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses. CMAJ 2009;181:488–493.
23. American Psychiatric Association. Practice guideline for the treatment of patients with substance use disorders, 2nd edn. American Psychiatric Association Practice Guidelines for the Treatment of Psychiatric Disorders 2004. Arlington, VA: American Psychiatric Publishing, Inc, 2006.
24. Chou K-J, Chen H-K, Hung C-H, Chen T-T, Chen C-M, Wu B-J. Readiness to quit as a predictor for outcomes of smoking-reduction programme with transdermal nicotine patch or bupropion in a sample of 308 patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci 2014 [Epub ahead of print].
25. McNally L, Oyefeso A, Annan J et al. A survey of staff attitudes to smoking-related policy and intervention in psychiatric and general health care settings. J Public Health (Oxf) 2006;28:192–196.
26. Bloor RN, Meeson L, Crome IB. The effects of a non-smoking policy on nursing staff smoking behaviour and attitudes in a psychiatric hospital. J Psychiatr Ment Health Nurs 2006;13:188–196.
27. Dickens GL, Stubbs JH, Haw CM. Smoking and mental health nurses: a survey of clinical staff in a psychiatric hospital. J Psychiatr Ment Health Nurs 2004;11:445–451.
28. Tsoi DT, Porwal M, Webster AC. Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database Syst Rev 2013;2:CD007253.
29. Bennett ME, Wilson AL, Genderson M, Saperstein AM. Smoking cessation in people with schizophrenia. Curr Drug Abuse Rev 2013;6:180–190.
30. Englisch S, Morgen K, Meyer-Lindenberg A, Zink M. Risks and benefits of bupropion treatment in schizophrenia: a systematic review of the current literature. Clin Neuropharmacol 2013;36:203–215.
31. Kishi T, Iwata N. Varenicline for smoking cessation in people with schizophrenia: systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci 2014 [Epub ahead of print].
32. Evins AE, Hong LE, Kelly DL. T. Kishi and N. Iwata: Varenicline for smoking cessation in people with schizophrenia: systematic review meta-analysis. Eur Arch Psychiatry Clin Neurosci 2014 [Epub ahead of print].
33. McRobbie H, Bullen C, Hartmann-Boyce J, Hajek P. Electronic cigarettes for smoking cessation and reduction. Cochrane Database Syst Rev 2014;12:CD010216.
34. Grana R, Benowitz N, Glantz SA. E-cigarettes: a scientific review. Circulation 2014;129:1972–1986.
35. Caponnetto P, Auditore R, Russo C, Cappello GC, Polosa R. Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study. Int J Environ Res Public Health 2013;10:446–461.
36. Prochaska JJ, Grana RA. E-cigarette use among smokers with serious mental illness. PLoS ONE 2014;9:1–12.
37. Ussher MH, Taylor AH, Faulkner GEJ. Exercise interventions for smoking cessation. Cochrane Database Syst Rev 2014;8:CD002295.
38. Bernard P, Ninot G, Moullec G, Guillaume S, Courtet P, Quantin X. Smoking cessation, depression, and exercise: empirical evidence, clinical needs, and mechanisms. Nicotine Tob Res 2013;15:1635–1650.
39. Fagerström K, Aubin H-J. Management of smoking cessation in patients with psychiatric disorders. Curr Med Res Opin 2009;25:511–518.
40. Aveyard P, Begh R, Parsons A, West R. Brief opportunistic smoking cessation interventions: a systematic review and meta-analysis to compare advice to quit and offer of assistance. Addiction 2012;107:1066–1073.
41. Stead LF, Buitrago D, Preciado N, Sanchez G, Hartmann-Boyce J, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev 2013;5:CD000165.
42. Garcia-Portilla MP, Garcia-Alvarez L, Saiz PA et al. Effectiveness of a multi-component smoking cessation support programme (McSCSP) for patients with severe mental disorders: study design. Int J Environ Res Public Health 2013;11:373–389.
43. Mitchell A, Vancampfort D, De Hert M, Stubbs B. Do people with mental illness receive adequate smoking cessation advice? A systematic review and meta-analysis Gen Hosp Psychiatry 2015;37:14–23.
44. Szatkowski L, McNeill A. The delivery of smoking cessation interventions to primary care patients with mental health problems. Addiction 2013;108:1487–1494.
45. Cormac I, Brown A, Creasey S, Ferriter M, Huckstep B. A retrospective evaluation of the impact of total smoking cessation on psychiatric inpatients taking clozapine. Acta Psychiatr Scand 2010; 121: 393–397.
46. Aubin H-J, Farley A, Lycett D, Lahmek P, Aveyard P. Weight gain in smokers after quitting cigarettes: meta-analysis. BMJ 2012;345:1–21.
47. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2007;298:2654–2664.
48. Fagerstrom KO, Heatherton TF, Kozlowski LT. Nicotine addiction and its assessment. Ear Nose Throat J 1990;69:763–765.
49. Dixon LB, Medoff D, Goldberg R et al. Is implementation of the 5 A's of smoking cessation at community mental health centers effective for reduction of smoking by patients with serious mental illness? Am J Addict 2009;18:386–392.
50. A clinical practice guideline for treating tobacco use and dependence: 2008 update Panel, Liaisons, and Staff. A U.S. Public Health Service report. Am J Prev Med 2008;35:158–176.